首页> 外文期刊>Expert opinion on biological therapy >Efficacy of TachoSil a fibrin-based haemostat in different fields of surgery--a systematic review.
【24h】

Efficacy of TachoSil a fibrin-based haemostat in different fields of surgery--a systematic review.

机译:TachoSil是一种基于纤维蛋白的止血剂在不同手术领域的疗效-系统评价。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

BACKGROUND: Proper haemostasis is an important prerequisite for a successful outcome in all operative fields. TachoSil is used in many surgical specialties, especially for diffuse bleeding. However, TachoSil is not only used for haemostasis but also for closure of other anatomical structures. OBJECTIVE: To review the literature concerning the efficacy of TachoSil, a topical fibrin-based haemostat. METHODS: PubMed was searched for data on TachoSil and TachoComb from clinical trials and basic research. RESULTS/CONCLUSION: TachoSil is used in many surgical specialties and has proven to be a valuable tool for several indications. It also seems to be cost effective. Solid data from randomized controlled trials are available for liver surgery, thoracic surgery and urology where a positive value is clearly documented.
机译:背景:正确的止血是在所有手术领域取得成功的重要先决条件。 TachoSil用于许多外科专业,尤其是弥漫性出血。但是,TachoSil不仅用于止血,而且还用于其他解剖结构的闭合。目的:回顾有关TachoSil(一种基于局部纤维蛋白的止血药)疗效的文献。方法:从临床试验和基础研究中搜索PubMed以获得TachoSil和TachoComb的数据。结果/结论:TachoSil用于许多外科专业,并已被证明是用于多种适应症的有价值的工具。它似乎也具有成本效益。随机对照试验的可靠数据可用于肝脏手术,胸腔手术和泌尿科,这些文献明确记载了阳性值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号